Feasibility Study of fixed overlap field IMRT approach for mid and/or distal esophageal cancer with

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户：abc135abc

【摘要】

：

Objective: Proposed a new IMRT treatment planning technique with the potential of reducing low dose region of the lungs in esophageal cancer patients treated with defmitive chemoradiotherapy.

【作者】

：

Hao Chang Can Liang Hongqi Yu Dongjie He Suna Zhou Qiming Wang Zongyan Yu Qiuju Shao

【机构】

：

Department of Radiotherapy, TangDu Hospital, Fourth Military Medical University

【出处】

：

第十八届全国临床肿瘤学大会暨2015年CSCO学术年会

【发表日期】

：

2015年4期

【关键词】

：

esophageal cancer intensity modulated radiotherapy

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Objective: Proposed a new IMRT treatment planning technique with the potential of reducing low dose region of the lungs in esophageal cancer patients treated with defmitive chemoradiotherapy.

其他文献

中国非小细胞肺癌患者PD-L1的表达及与其它肺癌驱动基因的关系

目的：为了预估抑制PD-1/PD-L1单抗的单药治疗和/或联合治疗的受益人群,本研究对中国非小细胞肺癌患者进行了一系列肿瘤免疫治疗相关(PD-1,PD-L1和CTLA-4)和肿瘤靶向治疗相关(EGFR突变,KRAS突变,ALK,ROS1重组和MET)生物标记物的研究。

会议

非小细胞肺癌PD-L1生物标记物

基因组蓝图研究证实SRSF1是小细胞肺癌的关键驱动基因

目的：小细胞肺癌是预后较差的侵袭性肿瘤。大规模的测序研究已经揭示在各种恶性肿瘤中潜在的疾病驱动基因，但目前仍有许多未知驱动基因，特别是在亚洲患者。我们开展这项基因组蓝图研究，通过探索中国小细胞肺癌患者的综合遗传蓝图与详细的临床病史，试图找到DNA修复途径中能影响小细胞肺癌化疗疗效的关键复发性遗传改变。

会议

小细胞肺癌驱动基因SRSF1

非小细胞肺癌(NSCLC)腺癌和非腺癌组织学患者表皮生长因子受体(EGFR)突变的诊断性研究:IGNITE研究中国患者的数据

目的：IGNITE研究是一项大规模国际多中心的非干预性的诊断性研究(NCT01788163)，旨在测定患有腺癌和非腺癌组织学的进展期NSCLC患者中EGFR突变发生率。本文是针对中国患者数据进行进一步的分析。

会议

肺恶性肿瘤EGFR突变

在选定的晚期NSCLC患者中插入和维持使用吉非替尼联合化疗与单独化疗比较的一项多中心、随机Ⅲ期临床研究(ISCAN,CTONG-1102)

目的：本研究探索在选定人群的初治晚期NSCLC接受两周期吉西他滨/卡铂后疾病稳定(SD)的患者中，插入和维持使用吉非替尼联合化疗与单独化疗比较，是否能提高临床疗效和改善生存预后。方法：这是一项由全国14家研究中心参加的多中心随机Ⅲ期临床研究。

会议

肺腺癌EGFR突变状态吉非替尼

The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregul

Objective: Long noncoding RNAs (lncRNAs) comprises a group of RNA molecules defined as transcripts longer than 200 nucleotides that lack protein coding potential.Evidence is growing that lncRNAs are i

会议

the long noncoding RNA SPRY4IT1 proliferationhuma

Multiple-gene research and its clinical evaluation in Chinese hereditary breast cancer

Objective: Currently, dozens of susceptibility genes have been defined for hereditary breast cancer.Though several researches have proved the clinical utility of multiple-gene sequencing in assessment

会议

hereditary breast cancer multiple-gene sequencing BRCA1 BRCA2

RING finger protein 31 (RNF31) promotes P53 degradation in breast cancer cells

Objective: To investigate the role of RNF31 in relation to P53 signaling and proliferation in breast cancer.Method: Western blot, q-pcr, immune precipitation, flow cytometry, cell culture, microarray

会议

breast cancer RNF31P53

Serial Evaluation of Circulating MiRNAs Predictive of Res-ponse to Neoadjuvant Chemotherapy in Breas

Objective: Paradigm shifts to neoadjuvant chemotherapy(NACT) for locally advanced and operable breast cancer.Hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative

会议

circulating miRNAs breast cancerneoadjuvant chemo

High NK Cell Dose Predicts Improved Survival and ADCC Effect of Trastuzumab in HER-2 Positive Metast

Objective: Trastuzumab has been shown to medicate antibody dependent cell mediated cytotoxicity (ADCC) and inhibit HER-2.Associated Natural Killer (NK) cell with ADCC effect in metastatic breast cance

会议

metastatic breast cancer trastuzumab natural kille

ER-alpha promoter methylation is a specific biomarker for outcome prediction of cisplatin resistant

Objective: An increasing number of studies have suggested that the link between ERα methylation and triple-negative breast cancer (TNBC).We previously found the ERα methylation status in basal-like br

会议

TNBC ERα methylationcisplatin resistant

Feasibility Study of fixed overlap field IMRT approach for mid and/or distal esophageal cancer with

与本文相关的学术论文